62 related articles for article (PubMed ID: 2807152)
41. Markers as prognostic indicators in medullary thyroid carcinoma.
Mendelsohn G
Am J Clin Pathol; 1991 Mar; 95(3):297-8. PubMed ID: 1996539
[No Abstract] [Full Text] [Related]
42. Leu-M1 immunoreactivity and phaeochromocytoma.
Masmiquel L; Castro-Forns M; de Torres I; García A; Vidal MT; Simó R
J Clin Pathol; 1997 Feb; 50(2):168-70. PubMed ID: 9155703
[TBL] [Abstract][Full Text] [Related]
43. [Immunohistology and prognosis in thyroid cancer. Determination of the malignancy potential of papillary and medullary neoplasms by the detection of S-100 protein and Leu-M1 antigen].
Schröder S; Dralle H; Bay V; Böcker W
Acta Med Austriaca; 1989; 16(1):2-5. PubMed ID: 2711816
[TBL] [Abstract][Full Text] [Related]
44. [Pathological and clinical features of malignant thyroid tumors: classification, immunohistology, prognostic criteria].
Schröder S
Veroff Pathol; 1988; 130():1-159. PubMed ID: 3213226
[TBL] [Abstract][Full Text] [Related]
45. Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma.
el-Naggar AK; Ordonez NG; McLemore D; Schultz P; Hickey RC; Samaan N
Surgery; 1990 Dec; 108(6):981-5. PubMed ID: 2247844
[TBL] [Abstract][Full Text] [Related]
46. Medullary thyroid carcinoma: prognostic factors.
Riddell DA; Lampe HB; Cramer H; Troster M
J Otolaryngol; 1993 Jun; 22(3):180-3. PubMed ID: 7690409
[TBL] [Abstract][Full Text] [Related]
47. [DNA cytophotometry of oxyphilic thyroid tumors].
Pilch H; Back W; Winter J
Zentralbl Pathol; 1994 Feb; 139(6):433-6. PubMed ID: 8161492
[TBL] [Abstract][Full Text] [Related]
48. [Survival potentials of patients with papillary carcinoma of the thyroid gland in Hungary].
Esik O; Tusnády G; Daubner K; Németh G; Füzy M; Szentirmay Z
Orv Hetil; 1996 May; 137(20):1067-78. PubMed ID: 8657418
[TBL] [Abstract][Full Text] [Related]
49. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
Lanza G; Maestri I; Dubini A; Gafà R
Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
[TBL] [Abstract][Full Text] [Related]
50. Pathology of sporadic and hereditary medullary thyroid carcinoma.
Schröder S; Holl K; Padberg BC
Recent Results Cancer Res; 1992; 125():19-45. PubMed ID: 1448597
[No Abstract] [Full Text] [Related]
51. Prognostic factors in medullary thyroid carcinomas.
Schröder S; Dralle H
Horm Metab Res Suppl; 1989; 21():26-8. PubMed ID: 2807152
[TBL] [Abstract][Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]